AUTIFONY THERAPEUTICS LIMITED

AUTIFONY THERAPEUTICS LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Previous names
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameAUTIFONY THERAPEUTICS LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 07543962
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of AUTIFONY THERAPEUTICS LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is AUTIFONY THERAPEUTICS LIMITED located?

    Registered Office Address
    Stevenage Bioscience Catalyst
    Gunnels Wood Road
    SG1 2FX Stevenage
    Hertfordshire
    England
    Undeliverable Registered Office AddressNo

    What were the previous names of AUTIFONY THERAPEUTICS LIMITED?

    Previous Company Names
    Company NameFromUntil
    NEWINCCO 1091 LIMITEDFeb 25, 2011Feb 25, 2011

    What are the latest accounts for AUTIFONY THERAPEUTICS LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnSep 30, 2026
    Next Accounts Due OnJun 30, 2027
    Last Accounts
    Last Accounts Made Up ToSep 30, 2025

    What is the status of the latest confirmation statement for AUTIFONY THERAPEUTICS LIMITED?

    Last Confirmation Statement Made Up ToFeb 25, 2027
    Next Confirmation Statement DueMar 11, 2027
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToFeb 25, 2026
    OverdueNo

    What are the latest filings for AUTIFONY THERAPEUTICS LIMITED?

    Filings
    DateDescriptionDocumentType

    Group of companies' accounts made up to Sep 30, 2025

    39 pagesAA

    Confirmation statement made on Feb 25, 2026 with no updates

    3 pagesCS01

    replacement-filing-of-director-appointment-with-name

    3 pagesRP01AP01

    replacement-filing-of-director-appointment-with-name

    3 pagesRP01AP01

    Statement of capital on Oct 17, 2025

    • Capital: GBP 28,681.375
    12 pagesSH19

    legacy

    6 pagesSH20

    legacy

    6 pagesCAP-SS

    Resolutions

    Resolutions
    13 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolutions

    Reduce share prem a/c 02/10/2025
    RES13

    Group of companies' accounts made up to Sep 30, 2024

    39 pagesAA

    Appointment of Mrs Hannah Louise Selin as a secretary on May 07, 2025

    2 pagesAP03

    Confirmation statement made on Feb 25, 2025 with updates

    19 pagesCS01

    Statement of capital following an allotment of shares on Jul 29, 2024

    • Capital: GBP 28,681.375
    11 pagesSH01

    Statement of capital following an allotment of shares on Jul 29, 2024

    • Capital: GBP 28,636.375
    9 pagesSH01

    Group of companies' accounts made up to Sep 30, 2023

    38 pagesAA

    Memorandum and Articles of Association

    66 pagesMA

    Resolutions

    Resolutions
    3 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    RES10
    capital

    Resolutions

    Re-issue of equity securities 05/06/2024
    RES13
    capital

    Resolution of removal of pre-emption rights

    RES11
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Confirmation statement made on Feb 25, 2024 with updates

    10 pagesCS01

    Statement of capital following an allotment of shares on Feb 26, 2024

    • Capital: GBP 27,436.375
    8 pagesSH01

    Termination of appointment of Atul Chandra Pande as a director on Jan 31, 2024

    1 pagesTM01

    Statement of capital following an allotment of shares on Nov 23, 2023

    • Capital: GBP 27,111.375
    8 pagesSH01

    Statement of capital following an allotment of shares on Oct 12, 2023

    • Capital: GBP 27,086.375
    8 pagesSH01

    Group of companies' accounts made up to Sep 30, 2022

    38 pagesAA

    Confirmation statement made on Feb 25, 2023 with updates

    10 pagesCS01

    Statement of capital following an allotment of shares on Jan 30, 2023

    • Capital: GBP 27,056.375
    8 pagesSH01

    Cessation of Pfizer Inc as a person with significant control on Jan 12, 2023

    1 pagesPSC07

    Who are the officers of AUTIFONY THERAPEUTICS LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    SELIN, Hannah Louise
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    Secretary
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    335527050001
    AL-HALLAQ, Rana
    E 42nd St,
    235/15/52
    NY 10017 New York
    235
    United States
    Director
    E 42nd St,
    235/15/52
    NY 10017 New York
    235
    United States
    United StatesAmerican257680720001
    BERRIMAN, John Edward
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    Director
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    EnglandBritish160360990004
    BINGHAM, Catherine Elizabeth, Dame
    71 Kingsway
    WC2B 6ST London
    Sv Life Sciences Advisers Llp
    United Kingdom
    Director
    71 Kingsway
    WC2B 6ST London
    Sv Life Sciences Advisers Llp
    United Kingdom
    United KingdomBritish48792460001
    LARGE, Charles Henry
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    Director
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    EnglandBritish160360700002
    IP2IPO SERVICES LIMITED
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    England
    Director
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    England
    Identification TypeUK Limited Company
    Registration Number05325867
    122951520001
    OLSWANG COSEC LIMITED
    High Holborn
    WC1V 6XX London
    90
    Secretary
    High Holborn
    WC1V 6XX London
    90
    Identification TypeEuropean Economic Area
    Registration Number04051235
    83864780002
    ALVARO, Giuseppe
    High Holborn
    WC1V 6XX London
    90
    United Kingdom
    Director
    High Holborn
    WC1V 6XX London
    90
    United Kingdom
    ItalyItalian160361280001
    BAXTER, Allan
    Imperial College Incubator
    Level 1 Bessemer Building Imperial College
    SW7 2AZ London
    B205
    United Kingdom
    Director
    Imperial College Incubator
    Level 1 Bessemer Building Imperial College
    SW7 2AZ London
    B205
    United Kingdom
    United KingdomBritish164925950001
    BHAMAN, Maina
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    Director
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    United KingdomBritish164825140001
    JONES, Elaine, Dr
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    Director
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    United StatesAmerican183683640001
    MACKIE, Christopher Alan
    High Holborn
    WC1V 6XX London
    90
    Director
    High Holborn
    WC1V 6XX London
    90
    United KingdomBritish137231800001
    PANDE, Atul Chandra, Dr
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    Director
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    United StatesAmerican194611900002
    SONI, Bobby G., Dr
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    Director
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Bioscience Catalyst
    Hertfordshire
    England
    United KingdomAmerican242032160001
    OLSWANG DIRECTORS 1 LIMITED
    High Holborn
    WC1V 6XX London
    90
    Director
    High Holborn
    WC1V 6XX London
    90
    Identification TypeEuropean Economic Area
    Registration Number04058026
    94701880001
    OLSWANG DIRECTORS 2 LIMITED
    High Holborn
    WC1V 6XX London
    90
    Director
    High Holborn
    WC1V 6XX London
    90
    Identification TypeEuropean Economic Area
    Registration Number4058057
    136043260001

    Who are the persons with significant control of AUTIFONY THERAPEUTICS LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Pfizer Inc
    New York
    New York 10017
    235 East 42nd Street
    United States
    Nov 01, 2021
    New York
    New York 10017
    235 East 42nd Street
    United States
    Yes
    Legal FormIncorporated
    Country RegisteredUnited States Of America
    Legal AuthorityUnited States Of America
    Place RegisteredDelaware
    Registration Number13-5315170
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    Svls Life Sciences Fund V Lp
    201 Washington Street
    Suite 3900
    Boston
    One Boston Place
    Mass
    United States
    Apr 06, 2016
    201 Washington Street
    Suite 3900
    Boston
    One Boston Place
    Mass
    United States
    Yes
    Legal FormLimited Partnership
    Legal AuthorityUs Entity
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    Touchstone Innovations Businesses Llp
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    England
    Apr 06, 2016
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    England
    No
    Legal FormLlp
    Country RegisteredUk
    Legal AuthorityLimited Liability Partnership Act
    Place RegisteredUk
    Registration NumberOc333709
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0